Weitz & Luxenberg is accepting new Fosamax femur fracture cases as FDA determines drug’s future
The FDA announced September 6, 2011 that it is planning to undertake a review of Merck’s drug Fosamax to help determine whether health risks that it poses warrant federal action. The drug, proscribed to treat osteoporosis, has come under increasing scrutiny as studies linking Fosamax and femur fractures have emerged.
The announcement comes in the wake of increasingly convincing evidence linking Fosamax and femur fractures. The studies suggest that exposure to Fosamax for more than 3 to 5 years can be dangerous, leading to brittle bones that can weaken normally strong femur bones and cause spontaneous fractures.
The FDA said that that its main agenda is determining whether women taking Fosamax will be advised to take “drug holidays” – extended breaks away from the medicine intended to reduce the dangers of prolonged exposure to Fosamax. The FDA also plans to conduct a review of a decade and a half of data, none of which has shown that Fosamax is safe to use for prolonged periods.
This risk could ultimately lead to the FDA banning long-term use of Fosamax, and is likely to elicit some form of response, perhaps in the form of stronger warnings.
Some of the medical evidence suggests that Fosamax, which prevents certain bone renewal processes, may cause women’s femurs to add brittle bone mass, creating the appearance of strength while the bone is actually becoming weaker.
The FDA announcement is a major headline for both Merck and osteoporosis sufferers. Women who have taken Fosamax stand to gain information about the risks posed by Fosamax femur fractures. Meanwhile, Merck will get more insight into the reality of the potential liability they face.
The pharmaceutical giant has been accused of providing insufficient warnings about the risks their product poses. The FDA has required Merck to label its products with warnings about bone-related side effects since 2006, but warnings related to Fosamax femur fractures began to be included only last year.
Women affected by Fosamax have begun to pursue their legal options against Merck. Hundreds of Fosamax lawsuits have already been filed, alleging that exposure to the drug caused femur fractures. Weitz & Luxenberg is a leader among those providing informational resources and representation to Fosamax femur fracture clients.
Weitz & Luxenberg has deep experience with Fosamax femur fractures and Fosamax lawsuits. To get more information or ask a question, please fill out the form at the top of this page.
FDA Warning FDA Warning: Fosamax causes femur fracture and brittle bones
FDA releases warnings concerning the connection between Fosamax and femur fracture
Fosamax Side Effects Fosamax side effects & dangers causes serious bone & esophageal problems
Fosamax is known to cause serious side effects for its long-term users
Fosamax Fosamax Femur Fracture Lawsuits, Litigation, Lawyers & Attorney
Fosamax lawsuit for Femur Fractures and a class action lawsuits may start for Fosamax broken bone victims.